Family · Pharmaceutical analytical standards
Pitolisant
An antagonist and inverse agonist of the histamine H3 receptor, approved in the European Union in 2016 for narcolepsy: it increases histamine release in the brain, promoting wakefulness. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?The H3 receptor was discovered in 1983 by the Frenchman Jean-Charles Schwartz with his colleagues Arrang and Garbarg; decades later Schwartz himself developed pitolisant.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
